FOLIO · Positioning
What Artera is engineered for
Artera (rebranded from WELL Health in 2022) is engineered around three things: scale, integration depth, and broad SMS-and-voice operations across the patient lifecycle. Scale: the platform reports handling over a billion patient messages a year across its customer base, with the operational infrastructure (carrier relationships, deliverability monitoring, retry logic, opt-out handling at enterprise volume) to support that reliably. For an organisation operating at health-system scale (thousands of providers, millions of patient touches a year), reliability at that volume is not a given and is genuinely differentiated.
Integration depth: Artera's published EHR and PMS integration list covers Epic, Cerner, MEDITECH, Allscripts, Athenahealth, eClinicalWorks, NextGen, and several smaller systems, with bi-directional real-time data exchange on the major systems. For a multi-EHR health system (the result of acquisitions or service-line history) where different sites run on different EHR platforms, Artera's ability to operate consistently across that mix is one of its strongest claims.
Broad operations: the platform supports the full patient communication lifecycle in one stack. Pre-visit (reminders, two-way confirmation, intake), at-visit (check-in, payment), post-visit (feedback, recall, follow-up), and broadcast (population-health campaigns, vaccine outreach, screening recall). For organisations consolidating from several point solutions, the breadth simplifies operations even when individual modules are not the absolute best-of-breed.
FOLIO · Worked ROI
10-hospital regional system: $8M recovered, $250K spent
System profile: 10 hospitals and ambulatory sites, 700 employed providers, approximately 2 million scheduled appointments a year, blended $260 per visit. Baseline no-show rate weighted across primary care, specialty, and behavioural health: 16 percent. Baseline missed appointments: 320,000. Direct revenue impact: $83M charges, approximately $55M collected.
Artera implementation with two-stage SMS, voice fallback, two-way confirmation, broadcast outreach for screening and vaccine campaigns, and integrated active waitlist. Expected reduction: 30 percent (mid-range JMIR, somewhat tempered by the difficulty of moving the needle at scale on a heterogeneous patient population). New rate: 11.2 percent. New missed appointments: 224,000. Recovery: 96,000 appointments, $25M charges, $16.5M collected.
Adjusted for substitution, attribution, and population-health-campaign contribution: incremental annual recovery in the range of $8M to $12M. Artera cost at this scope: approximately $250,000 to $350,000 a year subscription plus $100,000 amortised one-time implementation. ROI: 25x to 40x first year. At enterprise scale the ROI math is dominated by the absolute dollar recovery rather than the percentage; reducing no-shows by 5 percentage points on a 2-million-appointment base is millions of dollars even at modest reduction percentages.
The enterprise decision is rarely about headline ROI alone (which is overwhelmingly positive for any credible platform at this scale). The decision is about operational fit, EHR integration depth, support model, and vendor stability. Artera is one of the credible answers in that decision; Luma Health, EpicCare native messaging, Cerner native messaging, and a small set of other enterprise platforms are the others.
FOLIO · Integration list
EHR and PMS integrations, real-time depth
Artera's published integration list covers the major enterprise EHR and PMS systems with bi-directional real-time integration: Epic (App Orchard certified, deep integration including Cogito reporting hooks), Cerner (Cerner Open certified), MEDITECH, Allscripts, Athenahealth, eClinicalWorks, NextGen, AdvancedMD, and several smaller systems. The depth of integration varies by EHR; Epic and Athenahealth are the most mature, Cerner and MEDITECH are well-supported with somewhat narrower automation hooks.
For mixed-EHR environments (which are common in regional health systems after acquisitions), Artera operates as a unified patient communication layer that hides the EHR heterogeneity from clinical operations. Patient messages, confirmations, and waitlist outreach work consistently across the site mix even when underlying EHRs differ. This is a meaningful operational simplification for organisations dealing with EHR fragmentation.
For organisations on a single EHR with strong native patient communication (Epic MyChart messaging, for example), the case for an external platform is more nuanced. Some organisations on full Epic stacks decide native is sufficient. Others choose Artera (or Luma Health) because the external platform delivers richer broadcast capability, more sophisticated waitlist logic, or deeper analytics than the native module currently offers.
FOLIO · Alternatives
When to look at something else
For a single-location practice (1 to 10 providers), Artera is the wrong category. SolutionReach, Phreesia, NexHealth, or Weave will deliver comparable reminder outcomes at one-tenth the cost. For a small multi-site group (2 to 5 locations, 10 to 30 providers), Artera is at the bottom of its sweet spot and SolutionReach Enterprise or NexHealth Multi-Location should be in the same evaluation. For a large multi-site health system, Artera is one of the credible options and the head-to-head decision is typically against Luma Health, with EHR-native communication as a third option for full-Epic or full-Cerner organisations.
The downsides of Artera at enterprise scale are the standard enterprise-software downsides: implementation timeline (6 to 12 months for a large health system), customisation depth that can take time to optimise, contract terms that lock the organisation in for multiple years, and the operational complexity of running a platform integrated into clinical workflows across many sites. Procurement teams evaluating Artera should plan for at least 6 months of internal preparation and 9 to 12 months of phased rollout for a multi-site deployment.
Despite the cost and complexity, organisations at the right scale consistently report Artera delivers the operational consolidation and the SMS reliability they signed up for. Customer satisfaction scores in KLAS Research and G2 are typically in the 4.3 to 4.6 range, reflecting solid execution against the enterprise mandate.
FOLIO · Related
Related folios
FOLIO · Margin notes
Frequently asked questions
How much does Artera cost?+
Artera (formerly WELL Health) does not publish pricing publicly. Customer-reported pricing in 2025 to 2026 starts around $20,000 to $30,000 per year for a multi-site mid-market deployment (5 to 10 locations) and scales to several hundred thousand dollars annually for large hospital systems. Pricing is typically structured as a base platform fee plus per-patient-volume metering plus implementation fee. Multi-year contracts (3 to 5 years) with annual escalators are standard.
What does Artera do?+
Enterprise patient communication and engagement: two-stage SMS appointment reminders, voice fallback and live-agent escalation, two-way patient messaging with intelligent reply routing, active cancellation waitlist, broadcast SMS outreach for population-health campaigns (flu shot push, screening recall, vaccine outreach), digital intake, payment workflows, post-visit feedback, and recall and recare automation. The platform's distinguishing claim is SMS scale and reliability: Artera reports handling over 1 billion patient messages annually across its customer base, with the operational infrastructure to support that volume reliably.
How does Artera compare to Luma Health?+
Both are enterprise patient engagement platforms competing for the same large multi-site health system segment. Artera's positioning emphasises SMS scale, broad messaging operations, and integration depth across the major EHRs. Luma Health emphasises AI-driven outreach prioritisation and scheduling. In competitive selections the two often emerge as the final candidates. The choice tends to come down to EHR integration depth on the specific systems in use, reference customer profile alignment, and operational philosophy (Artera leans toward broad messaging-first, Luma Health leans toward intelligence-led outreach). Both are credible at enterprise scale.
Is Artera worth it for a mid-market practice?+
Yes for the upper end of mid-market (10 plus locations, 50 plus providers, complex EHR environment) where the platform's scale capability and integration depth justify the price. For smaller mid-market practices (3 to 8 providers, single or two locations) the price is hard to justify against SolutionReach at $400 to $800 per month, which delivers comparable reminder outcomes at a fraction of the cost. The Artera value proposition is meaningful when patient volume per site is high, when broadcast outreach for population health is a strategic need, and when EHR integration depth has been a pain point with prior vendors.